Management of cutaneous lupus erythematosus

Cutaneous Lupus Erythematosus

Volumn , Issue , 2005, Pages 437-444

  Callen, Jeffrey P ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955520914     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/3-540-26581-3_31     Document Type: Chapter

References (35)

1. Atra E, Sato EI (1993) Treatment of cutaneous lesions of systemic lupus erythematosus with thalidomide. Clin Exp Rheumatol 11:487-493
2. Bleumink GS, ter Borg EJ, Ramselaar CG, Ch Stricker BH (2001) Etanercept-induced subacute cutaneous lupus erythematosus. Rheuamtology (Oxford) 40:1317-1319
3. Boehm IB, Boehm GA, Bauer R (1998) Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms. Rheumatol Int 18:59-62
4. Bonsmann G, Schiller M, Luger TA, Stander S (2001) Terbinafine-induced subacute cutaneous lupus erythematosus. J Am Acad Dermatol 44:925-931
5. Callen JP, Kulp-Shorten CL, Hughes AP (2001) Subacute cutaneous lupus erythematosus associated with terbinafine therapy. Arch Dermatol 137:1196-1198
6. Callen JP, Spencer LV, Burruss JB, Holtman J (1991) Azathioprine: an effective, corticosteroidssparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis. Arch Dermatol 127:515-522
7. Callen JP (2001) Therapy of cutaneous lupus erythematosus. Dermatologic Therapy 14:61-69
8. Crowson AN, Magro CM (1997) Subacute cutaneous lupus erythematosus arising in the setting of calcium channel blocker therapy. Hum Pathol 28:67-73
9. Dalziel K, Going G, Cartwright PH, Marks R, Beveridge GW, Rowell NR (1986) Treatment of chronic discoid lupus erythematosus with an oral gold compound (Auranofin) Br J Dermatol 115:211-216
10. Delaporte E, Catteau B, Sabbagh N, Gosselin P, Breuillard F, Doutre MS, Broly F, Piette F, Bergoend H (1997) Traitment du lupus erythemateux chronique par la sulfasalazine: 11 observations. Ann Dermatol Venereol 124:151-156
11. Duong JD, Spigel T, Moxley R T III, Gaspari AA (1999) American experience with low-dose thalidomide therapy for severe cutaneous lupus erythematosus. Arch Dermatol 135:1079-1087
12. Feldmann R, Salomon D, Saurat JH (1994) The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus. Dermatology 189:425-427
13. Gallego H, Crutchfield CE III, Lewis EJ, Gallego HJ (1999) Report of an association between discoid lupus erythematosus and smoking. Cutis 63:231-234
14. Genereau T, Chosidow O, Danel C, Cherin P, Herson S (1999) High-dose intravenous immunoglobulin in cutaneous lupus erythematosus. Arch Dermatol 135:1124-1125
15. Goyal S, Nousari HC (2001) Treatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetil. J Am Acad Dermatol 45:142-144
16. Jewell ML, McCauliffe DP (2000) Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. J Am Acad Dermatol 42:983-987
17. Krivanek J F C, Paver W K A (1980) Further study of the use of clofazimine in discoid lupus erythematosus. Australasian J Dermatol 21:169-171
18. Lagrange S, Piette JC, Becherel PA, Cacoub P, Frances C (1998) Sulfasalazine in the treatment of cutaneous lupus erythematosus: open trial in six cases. Lupus 7:21
19. Lagrange S, Frances C, Roy S, Papo T, Piette JC (2004) High dose intravenous immune globulin in the treatment of refractory severe discoid lupus erythematosus. J Am Acad Dermatol, in press
20. Lehmann P, Holzle E, Kind P, Goerz G, Plewig G (1990) Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol 22:181-187
21. Millard TP, Hawk J L M, McGregor JM (2000) Photosensitivity in lupus. Lupus 9:3-10
22. Neri R, Mosca M, Bernacchi E, Bombardieri S (1999) A case of SLE with acute, subacute and chronic cutaneous lesions successfully treated with dapsone. Lupus 8:240-243
23. Newton RC, Jorizzo JL, Solomon AR, Sanchez R, Bell JD, Cavallo T (1986) Mechanism-oriented assessment of isotretinoin in chronic of Subacute cutaneous lupus erythematosus. Arch Dermatol 122:180-186
24. Nicolas JF, Thivolet J, Kanitkis J, Lyonnet S (1990) Response of discoid and Subacute cutaneous lupus erythematosus to recombinant interferon alpha 2a. J Invest Dermatol 95:142S-145S
25. Nyberg F, Hassan T, Puska P, Stephansson E, Hakkinen M, Ranki A, Ros AM (1997) Occurrence of polymorphous light eruption in lupus erythematosus. Br J Dermatol 136:217-221
26. Ordi-Ros J, Cortes F, Cucurull E, Mauri M, Bujan S, Vilardell M (2000) Thalidomide in the treatment of cutaneous lupus erythematosus refractory to conventional therapy. J Rheumatol 27:1429-1433
27. Pashinian N, Wallace DJ, Klinenberg JR (1998) Mycophenolate mofetil for systemic lupus erythematosus. Arthritis Rheum 41:S110
28. Prinz JC, Meurer M, Reiter C, Rieber EP, Plewig G, Riethmuller G (1996) Treatment of severe cutaneous lupus erythematosus with a chimeric CD4 monoclonal antibody, cM-T412. J Am Acad Dermatol 34:244-252
29. Rahman P, Gladman DD, Urowitz MB (1998) Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus. J Rheumatol 25:1716-1719
30. Reed BR, Huff JC, Jones SK, Orton PW, Lee LA, Norris DA (1985) Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. Ann Intern Med 103:49-51
31. Rodriquez-Castellanos MA, Rubio JB, Gomez J F B, Mendoza AG (1995) Phenytoin in the treatment of discoid lupus erythematosus. Arch Dermatol 131:620-621
32. Rudnicka L, Szymanska E, Walecka I, Stowinska M (2000) Long-term cefuroxime axetil in subacute cutaneous lupus erythematosus. A report of three cases. Dermatology 200:129-131
33. Ruzicka T, Meurer M, Brown-Falco O (1985) Treatment of cutaneous lupus erythematosus with etretinate. Acta Derm Venereol 65:324-329
34. Stege H, Budde MA, Grether S, Krutmann J (2000) Evaluation of the capacity of sunscreens to photoprotect lupus erythematosus patients by employing the photoprovocation test. Photodermatol Photoimmunol Photomed 16:256-259
35. Tebbe B, Lauy M, Gollnick H (1992) Therapy of cutaneous lupus erythematosus with recombinant interferon alpha-2a. Eur J Dermatol 2:253-255